Clinical Trials Directory

Trials / Completed

CompletedNCT02006524

Screening for Silent Atrial Fibrillation During Influenza Vaccination

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
3,269 (actual)
Sponsor
UMC Utrecht · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Silent atrial fibrillation is an important cause of unnecessary strokes. If diagnosed and treated in time with anticoagulants, many disabling strokes can be prevented. In order to improve the diagnosis of atrial fibrillation the MyDiagnostick is developed; a user friendly and easy to use stick that diagnoses atrial fibrillation in one minute. During influenza vaccination, many patients who are also at risk for atrial fibrillation visit the general practice. This offers an ideal opportunity for screening for atrial fibrillation. The study investigates the yield of screening for atrial fibrillation with the MyDiagnostick during influenza vaccination (newly detected atrial fibrillation with corresponding CHA2DS2-Vasc score).

Conditions

Interventions

TypeNameDescription
DEVICE'MyDiagnostick

Timeline

Start date
2013-10-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2013-12-10
Last updated
2016-05-12

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02006524. Inclusion in this directory is not an endorsement.

Screening for Silent Atrial Fibrillation During Influenza Vaccination (NCT02006524) · Clinical Trials Directory